Neuroform Ez 3
Payments companies reported to CMS as associated with Neuroform Ez 3. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Neuroform Ez 3, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Neuroform Ez 3
These are the largest totals companies reported as associated with Neuroform Ez 3. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Geoffrey Colby | Los Angeles, CA | Neurological Surgery | $20,469.44 |
| Italo Linfante | Miami, FL | Neuroradiology | $14,248.30 |
| Justin Singer | Grand Rapids, MI | Neurological Surgery | $12,761.65 |
| Justin Mascitelli | San Antonio, TX | Neurological Surgery | $5,607.31 |
| Sohyun Boo | Morgantown, WV | Neuroradiology | $1,425.00 |
| Ehsan Dowlati | Washington, DC | Neurological Surgery | $1,340.99 |
| Sudhakar Satti | Paoli, PA | Neuroradiology | $1,004.16 |
| Jihad Abdelgadir Imam Mohamed Ahmed | Salt Lake City, UT | Neurological Surgery | $1,004.16 |
| Matthew Tobin | Indianapolis, IN | $1,004.16 | |
| Clayton Gerndt | Sacramento, CA | Neurological Surgery | $972.51 |
Prescribed Neuroform Ez 3?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.